Pieris Pharmaceuticals
在场
Pieris Pharmaceuticals 是一家在股票代码 PIRS (US) 下上市的公司。
高管
查看带有其 11 名主要高管的组织结构图
Pieris Pharmaceuticals 搜索最多的简介
- Stephen Yoder, Director, President and Chief Executive Officer
- James Geraghty, Chairman of the Board
- Ann Barbier, Director
高管在Pieris Pharmaceuticals变化
- Thomas Bures, Senior Vice President and Chief Financial Officer, 已经离开公司 (新闻发布的2025一月18号).
创建提醒
跟踪 Pieris Pharmaceuticals 的高管变动
药店
Pieris Pharmaceuticals 拥有 1,833 家竞争者，其中包括 Pfizer (美国(美洲))、Sanofi (法国) 和 Roche (瑞士)。
Popular M&A news in 药店
- Knight Therapeutics has announced the acquisition of Paladin Labs (公布2025三月12号).
- Jazz Pharmaceuticals 已收购 Chimerix (公布2025三月6号).
- Cosette Pharmaceuticals has announced the acquisition of Mayne Pharma (公布2025二月25号).
药店 行业的其他推荐联系人
消息
Pieris Pharmaceuticals 的最新新闻稿
- 2024 Annual Meeting of Stockholders
- Palvella Therapeutics and Pieris Pharmaceuticals Announce Definitive Merger Agreement
- Palvella Therapeutics and Pieris Pharmaceuticals, Inc. Announce Merger Agreement
- Pieris Pharmaceuticals Announces 1-for-80 Reverse Stock Split
- Pieris Pharmaceuticals Announces Strategy to Maximize Partnered Milestone and Royalty Potential
- Pieris Pharmaceuticals Announces Milestone Achievement for Boston Pharmaceuticals' Initiation of Phase 1/2 Study of BOS-342, a 4-1BB/GPC3 Immuno-Oncology Bispecific
- Pieris Pharmaceuticals Provides Strategic Update and Announces Restructuring
- Jefferies Healthcare Conference
- Pieris Pharmaceuticals Announces AstraZeneca Discontinuation of Phase 2a Trial of Elarekibep (PRS-060/AZD1402) Due to New Non-Clinical Safety Findings From 13-week Toxicology Study
- Pieris Pharmaceuticals to Present at Jefferies 2023 Healthcare Conference
- View more press releases Close
